EUVIMEDEUVIMED entdecken
Multizentrische Studie

Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases

Khalaf Kridin iD, Marie-Charlotte Brüggen iD, Sarah Walsh, Benoit Bensaid, Annamari Ranki, Eva Oppel, Damian Meyersburg iD, Ser-Ling Chua, Corsin Seeli, Heidi Sandberg, Lars E French iD, Artem Vorobyev und 1 weitere

Journal of the European Academy of Dermatology and Venereology · 2023-04 · 37 (4) · 753-762

DOI: 10.1111/jdv.18808 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 19.12.2022. Verfasst von Khalaf Kridin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Drug Hypersensitivity Syndrome, Eosinophilia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but potentially fatal drug hypersensitivity reaction.

Objective

To explore treatment approaches across Europe and their impact on the disease course, as well as prognostic factors and culprit drugs.

Methods

In this retrospective European multicentric study, we included patients with probable or certain DRESS (RegiSCAR score ≥ 4) between January 2016 and December 2020. Independent associations between clinical parameters and the risk of intensive care unit admission and mortality at three months were assessed using a multivariable‐adjusted logistic regression model.

Results

A total of 141 patients from 8 tertiary centres were included. Morbilliform exanthem was the most frequent cutaneous manifestation (78.0%). The mean affected body surface area (BSA) was 67%, 42% of the patients presented with erythroderma, and 24.8% had mucosal involvement. Based on systemic involvement, 31.9% of the patients had a severe DRESS. Anticonvulsants (24.1%) and sulphonamides (22.0%) were the most frequent causative agents. In all, 73% of the patients were treated with systemic glucocorticoids, and 25.5% received topical corticosteroids as monotherapy. Few patients received antiviral drugs or anti‐IL5. No patients received intravenous immunoglobulins. The overall mortality was 7.1%. Independent predictors of mortality were older age (≥57.0 years; fully adjusted OR, 9.80; 95% CI, 1.20–79.93; p = 0.033), kidney involvement (fully adjusted OR, 4.70; 95% CI, 1.00–24.12; p = 0.049), and admission in intensive care unit (fully adjusted OR, 8.12; 95% CI, 1.90–34.67; p = 0.005). Relapse of DRESS and delayed autoimmune sequelae occurred in 8.5% and 12.1% of patients, respectively.

Conclusions

This study underlines the need for diagnostic and prognostic scores/markers as well as for prospective clinical trials of drugs with the potential to reduce mortality and complications of DRESS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Hypersensitivity SyndromeEosinophiliaHumansRetrospective StudiesProspective StudiesTreatment OutcomeGlucocorticoids

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
  • Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Medical Campus Davos, Davos, Switzerland.
  • ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).

ORCID-Profile: Khalaf Kridin, Marie-Charlotte Brüggen, Damian Meyersburg, Lars E French, Saskia Ingen-Housz-Oro

Zitieren

APA

Kridin, K., Brüggen, M. C., Walsh, S., Bensaid, B., Ranki, A., Oppel, E., Meyersburg, D., Chua, S. L., Seeli, C., Sandberg, H., French, L. E., Vorobyev, A., & Ingen-Housz-Oro, S. (2023). Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases. Journal of the European Academy of Dermatology and Venereology, 37(4), 753-762. https://doi.org/10.1111/jdv.18808

Vancouver

Kridin K, Brüggen MC, Walsh S, Bensaid B, Ranki A, Oppel E, et al. Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases. Journal of the European Academy of Dermatology and Venereology. 2023;37(4):753-762. doi:10.1111/jdv.18808

BibTeX
@article{Kridin2023,
  author = {Kridin, Khalaf and Brüggen, Marie-Charlotte and Walsh, Sarah and Bensaid, Benoit and Ranki, Annamari and Oppel, Eva and Meyersburg, Damian and Chua, Ser-Ling and Seeli, Corsin and Sandberg, Heidi and French, Lars E and Vorobyev, Artem and Ingen-Housz-Oro, Saskia},
  title = {Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {4},
  pages = {753--762},
  doi = {10.1111/jdv.18808}
}
Kostenlos starten →